Cargando…
Association between Anti-Hepatitis C Viral Intervention Therapy and Risk of Sjögren’s Syndrome: A National Retrospective Analysis
Hepatitis C virus (HCV) infection is a potential risk factor for Sjögren’s syndrome (SS). However, it is unclear whether anti-HCV intervention therapy could decrease SS risk. A retrospective cohort analysis from 1997–2012 comprising 17,166 eligible HCV-infected adults was conducted. By 1:2 propensit...
Autores principales: | Tung, Chien-Hsueh, Chen, Yen-Chun, Chen, Yi-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332495/ https://www.ncbi.nlm.nih.gov/pubmed/35893350 http://dx.doi.org/10.3390/jcm11154259 |
Ejemplares similares
-
Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database
por: Tung, Chien-Hsueh, et al.
Publicado: (2018) -
Risk of asthma in patients with primary Sjögren’s syndrome: a retrospective cohort study
por: Shen, Te-Chun, et al.
Publicado: (2016) -
Sjögren's syndrome with nodular pulmonary amyloidosis
por: Wu, Chang‐Wei, et al.
Publicado: (2020) -
Sjögren’s Syndrome and Viral Infections
por: Liu, Zhiyong, et al.
Publicado: (2021) -
Hepatitis C Viral Replication Complex
por: Li, Hui-Chun, et al.
Publicado: (2021)